Transcept Pharmaceuticals (TSPT) receives a $10M milestone payment from Purdue Pharma following...

|By:, SA News Editor

Transcept Pharmaceuticals (TSPT) receives a $10M milestone payment from Purdue Pharma following the FDA's inclusion of Intermezzo formulation patents in its Orange Book last week. The payment is part of an agreement between the two parties for the U.S. commercialization of the drug to be launched in Q2 of 2012. Shares +0.7% AH.